These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2371030)

  • 21. DNA ploidy analysis of endometrial adenocarcinoma using a flow cytometry from paraffin-embedded tissues.
    Takahashi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct; 42(10):1339-44. PubMed ID: 1700035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of morphometric nuclear grade of endometrial carcinoma.
    Salvesen HB; Iversen OE; Akslen LA
    Cancer; 1998 Sep; 83(5):956-64. PubMed ID: 9731900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases.
    Culton LK; Deavers MT; Silva EG; Liu J; Malpica A
    Am J Surg Pathol; 2006 Jul; 30(7):844-9. PubMed ID: 16819326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric analysis of uterine sarcomas.
    Lennart K; Lennart B; Ulf S; Bernard T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):339-42. PubMed ID: 7835771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastric cancer cell DNA content correlates with early and late results after gastrectomy.
    Carlini M; Garofalo A; Rinaldi G; D'Agnano I; D'Angelo C; Zupi G; Vecchione A; Santoro E
    Int Surg; 1994; 79(2):114-9. PubMed ID: 7928145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
    Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
    Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic indices in endometrial adenocarcinoma stages I and II. A study based on clinical, histopathological and flow cytometric variables.
    Wagenius G; Strang P; Bergström R; Stendahl U; Tribukait B
    Anticancer Res; 1991; 11(6):2137-42. PubMed ID: 1776852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [DNA content and survival in subserous gallbladder carcinoma].
    Roa I; de Aretxabala X; Fuentealba P; Cabrera ME; Araya JC; Roa J
    Rev Med Chil; 2004 Jul; 132(7):794-800. PubMed ID: 15379325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor.
    Ruà S; Comino A; Fruttero A; Torchio P; Bouzari H; Taraglio S; Torchio B; Capussotti L
    Cancer; 1996 Sep; 78(6):1195-202. PubMed ID: 8826940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor DNA content in gallbladder carcinoma.
    Sato Y; Tanaka J; Koyama K; van Gulik TM; Lygidakis NJ; van der Heyde MN
    Hepatogastroenterology; 1993 Aug; 40(4):375-9. PubMed ID: 8406309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is DNA aneuploidy a prognostic factor in gastric cancer?
    Omejc M; Repse S; Bracko M
    Acta Chir Hung; 1997; 36(1-4):266-9. PubMed ID: 9408370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of flow cytometric and clinical variables in endometrial adenocarcinoma stages I and II.
    Wagenius G; Bergström R; Strang P; Gerdes U; Rogo K; Tribukait B; Stendahl U
    Anticancer Res; 1992; 12(3):725-32. PubMed ID: 1622130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic implications of proliferative activity and DNA aneuploidy in Astler-Coller Dukes stage C colonic adenocarcinomas.
    Harlow SP; Eriksen BL; Poggensee L; Chmiel JS; Scarpelli DG; Murad T; Bauer KD
    Cancer Res; 1991 May; 51(9):2403-9. PubMed ID: 2015602
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of DNA ploidy status in patients with rectal cancer.
    Berczi C; Bocsi J; Bartha I; Math J; Balazs G
    Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA content in malignant salivary gland tumours.
    Monteiro LS; Palmeira C; Bento MJ; Lopes C
    Oral Dis; 2009 May; 15(4):295-301. PubMed ID: 19320959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [DNA content and cell cycle phase analysis in uterine sarcomas and its clinical significance].
    Tan X; Chen G
    Zhonghua Fu Chan Ke Za Zhi; 1999 Sep; 34(9):551-4. PubMed ID: 11360642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prognostic significance of cell kinetic parameters of endometrial cancer].
    Kühn W; Kaufmann M; Feichter GE; Rummel HH; Abel U; Heep J; von Minckwitz G
    Geburtshilfe Frauenheilkd; 1989 Sep; 49(9):787-92. PubMed ID: 2806852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Flow cytometric DNA analysis of uterine endometrial carcinoma].
    Izumi S; Yamaoka K; Arai H; Watanabe T; Tsutsui F; Tamura S; Nozawa S; Kurihara S
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Jul; 43(7):722-8. PubMed ID: 1890350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment failure in endometrial carcinoma.
    Burke TW; Heller PB; Woodward JE; Davidson SA; Hoskins WJ; Park RC
    Obstet Gynecol; 1990 Jan; 75(1):96-101. PubMed ID: 2296431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.